Su1543 VALIDATION OF THE LIVER RISK SCORE IN A NATIONALLY REPRESENTATIVE SAMPLE: A PROMISING NOVEL TOOL FOR PREDICTING FIBROSIS AND LIVER-RELATED OUTCOMES ...
Mo1503 GLOBAL PREVALENCE, CLINICAL CHARACTERISTICS, SURVEILLANCE, TREATMENT ALLOCATION, AND OUTCOMES OF ALCOHOL-ASSOCIATED HEPATOCELLULAR CARCINOMA: ...
Mo1535 THE ROLE OF ALCOHOL RELAPSE ON CLINICAL OUTCOMES AFTER TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT PLACEMENT
Mo1567 TREATMENT OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR (ICI) HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
103 STATIN THERAPY AND IMPROVED WAITLIST OUTCOMES IN LIVER TANS PANT CANDIDATES WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS
102 IMPACT OF BARIATRIC SURGERY ON HOSPITAL OUTCOMES IN PATIENTS ADMITTED WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A 2020 RETROSPECTIVE ANALYSIS IN THE ...
Tu1203 CLINICAL CHARACTERISTICS AND OUTCOMES OF SMALL BOWEL NEOPLASMS IN CROHN'S DISEASE: A CASE-CONTROL STUDY
Su1612 ACUTE PANCREATITIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH): IS IT ASSOCIATED WITH WORSE OUTCOMES?
Mo1530 WAITLIST AND POST-TRANSPLANT OUTCOMES OF MET-ALD ARE POORER COMPARED TO THOSE WITH ALD PATIENTS
Mo2023 RESOUCE UTILIZATION AND CLINICAL OUTCOMES IN PATIENTS ADMITTED WITH NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING IN RELATION TO TIMING OF ESOPHAGEAL ...